| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2016PLoSO..1157789P |
| P356 | DOI | 10.1371/JOURNAL.PONE.0157789 |
| P932 | PMC publication ID | 4919090 |
| P698 | PubMed publication ID | 27337142 |
| P50 | author | Aris Spathis | Q40274861 |
| Petros Karakitsos | Q57418076 | ||
| Konstantinos Kostikas | Q59559025 | ||
| P2093 | author name string | Matthias Griese | |
| Spyros Papiris | |||
| Stelios Loukides | |||
| Andriana I Papaioannou | |||
| Ilias Papanikolaou | |||
| Effrosyni D Manali | |||
| Ioannis Tomos | |||
| Aneza Roussou | |||
| Georgia Papadaki | |||
| Argyro Mazioti | |||
| Kyriakos Chainis | |||
| P2860 | cites work | Genetic interstitial lung disease | Q24626239 |
| Lung surfactant in subacute pulmonary disease | Q24807188 | ||
| CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis | Q24811707 | ||
| Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy | Q28200083 | ||
| A mutation in the surfactant protein C gene associated with familial interstitial lung disease | Q28201394 | ||
| Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease | Q28261260 | ||
| An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias | Q28298430 | ||
| An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management | Q28308246 | ||
| Pulmonary surfactants and their role in pathophysiology of lung disorders | Q28618339 | ||
| Standardization of Spirometry, 1994 Update. American Thoracic Society | Q29547574 | ||
| Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper | Q29614960 | ||
| Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype | Q30489186 | ||
| Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study | Q33301961 | ||
| Pulmonary surfactant in health and human lung diseases: state of the art. | Q33710309 | ||
| Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema | Q33855641 | ||
| Ageing and smoking contribute to plasma surfactant proteins and protease imbalance with correlations to airway obstruction | Q33876864 | ||
| ATS Statement | Q34136219 | ||
| Combined pulmonary fibrosis and emphysema | Q34325239 | ||
| Mechanical aspects of lung fibrosis: a spotlight on the myofibroblast | Q84578635 | ||
| The elevation of serum napsin A in idiopathic pulmonary fibrosis, compared with KL-6, surfactant protein-A and surfactant protein-D. | Q34410117 | ||
| Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. | Q34456830 | ||
| The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease | Q34546085 | ||
| Persistent Airway Inflammation and Emphysema Progression on CT Scan in Ex-Smokers Observed for 4 Years | Q35029745 | ||
| A computer-aided diagnosis system for quantitative scoring of extent of lung fibrosis in scleroderma patients | Q35225024 | ||
| Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF | Q35536294 | ||
| Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis | Q36028616 | ||
| Relation between duration of smoking cessation and bronchial inflammation in COPD | Q36183908 | ||
| Association between markers of emphysema and more severe chronic obstructive pulmonary disease | Q36225361 | ||
| Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers | Q36493973 | ||
| Value of serum and induced sputum surfactant protein-D in chronic obstructive pulmonary disease. | Q36897307 | ||
| Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. | Q37277707 | ||
| Role of lung surfactant in respiratory disease: current knowledge in large animal medicine | Q37385115 | ||
| Polymorphic variation in surfactant protein B is associated with COPD exacerbations. | Q37387050 | ||
| Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis | Q37799183 | ||
| Unifying thoracic biomarkers: surfactant protein-D and beyond | Q37997815 | ||
| The genetic basis of idiopathic pulmonary fibrosis | Q40777090 | ||
| The Diagnostic Value of the Interstitial Biomarkers KL-6 and SP-D for the Degree of Fibrosis in Combined Pulmonary Fibrosis and Emphysema | Q41894314 | ||
| Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred | Q42675595 | ||
| Why does airway inflammation persist after the smoking stops? | Q42743818 | ||
| Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis | Q43527848 | ||
| Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis | Q44589189 | ||
| Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease | Q45816467 | ||
| Stretch-induced Activation of Transforming Growth Factor-β1 in Pulmonary Fibrosis | Q48044574 | ||
| Systemic and airway inflammation and the presence of emphysema in patients with COPD. | Q48973423 | ||
| Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. | Q51669678 | ||
| Alveolar derecruitment and collapse induration as crucial mechanisms in lung injury and fibrosis. | Q51710127 | ||
| Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. | Q52019566 | ||
| Morphological disease progression of combined pulmonary fibrosis and emphysema: comparison with emphysema alone and pulmonary fibrosis alone. | Q53036800 | ||
| Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a dutch cohort. | Q54418482 | ||
| Idiopathic pulmonary fibrosis | Q56764887 | ||
| Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers | Q57892108 | ||
| Elevation of surfactant protein A in plasma and sputum in cigarette smokers | Q61851871 | ||
| Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals | Q63729276 | ||
| Two novel mutations in surfactant protein-C, lung function and obstructive lung disease | Q63729294 | ||
| Surfactant Protein-B 121ins2 Heterozygosity, Reduced Pulmonary Function, and Chronic Obstructive Pulmonary Disease in Smokers | Q63729297 | ||
| Evaluation of clinical methods for rating dyspnea | Q68267114 | ||
| Rapidly Reversible Alterations of Pulmonary Epithelial Permeability Induced by Smoking | Q70237365 | ||
| Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids | Q70785177 | ||
| Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers | Q71089627 | ||
| Surfactant protein deficiency in familial interstitial lung disease | Q74166791 | ||
| Prolonged survival in hereditary surfactant protein B (SP-B) deficiency associated with a novel splicing mutation | Q74228345 | ||
| Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent | Q74316652 | ||
| Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population | Q74598084 | ||
| Quantitation of emphysema with three-dimensional CT densitometry: comparison with two-dimensional analysis, visual emphysema scores, and pulmonary function test results | Q77400882 | ||
| Mutations in the surfactant protein C gene associated with interstitial lung disease | Q77763687 | ||
| Lung epithelium-specific proteins: characteristics and potential applications as markers | Q77932822 | ||
| Serum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smoking | Q81564771 | ||
| Combined pulmonary fibrosis and emphysema syndrome associated with familial SFTPC mutation | Q83239684 | ||
| SFTPC mutations in patients with familial pulmonary fibrosis: combined with emphysema? | Q83884189 | ||
| Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis | Q84435883 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pulmonary fibrosis | Q32446 |
| pulmonary emphysema | Q188605 | ||
| P304 | page(s) | e0157789 | |
| P577 | publication date | 2016-06-23 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE) | |
| P478 | volume | 11 |
Search more.